Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Koen B. Pouwels, Emma Pritchard, Philippa C. Matthews, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
Nick Andrews, Julia Stowe, Freja Kirsebom, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 16, pp. 1532-1546
Open Access | Times Cited: 2086
Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Noam Barda, Noa Dagan, Cyrille J. Cohen, et al.
The Lancet (2021) Vol. 398, Iss. 10316, pp. 2093-2100
Open Access | Times Cited: 860
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study
Anika Singanayagam, Seran Hakki, Jake Dunning, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 2, pp. 183-195
Open Access | Times Cited: 752
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
Hiam Chemaitelly, Patrick Tang, Mohammad R. Hasan, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 24
Open Access | Times Cited: 553
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
Xuemei He, Weiqi Hong, Xiangyu Pan, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 838-845
Open Access | Times Cited: 494
Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
David W. Eyre, Donald Taylor, M. B. Purver, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 8, pp. 744-756
Open Access | Times Cited: 438
SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
Marc Lipsitch, Florian Krammer, Gili Regev‐Yochay, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 57-65
Open Access | Times Cited: 305
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
Po Ying Chia, Sean Wei Xiang Ong, Calvin J. Chiew, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 4, pp. 612.e1-612.e7
Open Access | Times Cited: 295
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review
Ibrahim Mohammed, Areej Nauman, Pradipta Paul, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 281
SARS-CoV-2 vaccine protection and deaths among US veterans during 2021
Barbara A. Cohn, Piera M. Cirillo, Caitlin C. Murphy, et al.
Science (2021) Vol. 375, Iss. 6578, pp. 331-336
Open Access | Times Cited: 241
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern
Nick Andrews, Julia Stowe, Freja Kirsebom, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 188
mRNA Vaccines in the COVID-19 Pandemic and Beyond
Michael J. Hogan, Norbert Pardi
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 17-39
Open Access | Times Cited: 177
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 174
Vaccine effectiveness and duration of protection of Comirnaty, Vaxzevria and Spikevax against mild and severe COVID-19 in the UK
Nick Andrews, Elise Tessier, Julia Stowe, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 167
Willingness to Receive the Booster COVID-19 Vaccine Dose in Poland
Piotr Rzymski, Barbara Poniedziałek, Andrzej Fal
Vaccines (2021) Vol. 9, Iss. 11, pp. 1286-1286
Open Access | Times Cited: 148
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
Lindsey Wang, QuanQiu Wang, Pamela B. Davis, et al.
World Psychiatry (2021) Vol. 21, Iss. 1, pp. 124-132
Open Access | Times Cited: 124
Shedding of Infectious SARS-CoV-2 Despite Vaccination
Kasen K. Riemersma, Luis A. Haddock, Nancy A. Wilson, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 117
SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy
Ziwei Yang, Yang Han, Shilei Ding, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
The impact of SARS-CoV-2 vaccination on Alpha and Delta variant transmission
David W. Eyre, Donald Taylor, M. B. Purver, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 97
A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines
Parisa Ghasemiyeh, Soliman Mohammadi‐Samani, Negar Firouzabadi, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108162-108162
Open Access | Times Cited: 86
COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
Piotr Rzymski, Carlos A. Camargo, Andrzej Fal, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1299-1299
Open Access | Times Cited: 76
COVID-19 Delta Variant: Perceptions, Worries, and Vaccine-Booster Acceptability among Healthcare Workers
Khalid Alhasan, Fadi Aljamaan, Mohamad‐Hani Temsah, et al.
Healthcare (2021) Vol. 9, Iss. 11, pp. 1566-1566
Open Access | Times Cited: 69
Forecasting the COVID-19 effects on energy poverty across EU member states
Alfonso Carfora, Giuseppe Scandurra, Antonio Thomas
Energy Policy (2021) Vol. 161, pp. 112597-112597
Open Access | Times Cited: 61
Effectiveness of BNT162b2 (Comirnaty, Pfizer-BioNTech) COVID-19 booster vaccine against covid-19 related symptoms in England: test negative case-control study
Nick Andrews, Julia Stowe, Freja Kirsebom, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 61
Page 1 - Next Page

Scroll to top